Richard J. Mitrano, VP Finance & Operations at Frequency Therapeutics, Inc. (FREQ), sold 224 shares at $0.35 ($78) on 2023-07-06, disclosed to the SEC on 2023-07-12.
Scheduled sale ($78) by VP Finance & Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FREQ | SELL | 2023-08-16 | $301 | — | Filing → |
| FREQ | SELL | 2023-08-14 | $312 | — | Filing → |
| FREQ | SELL | 2023-08-10 | $319 | — | Filing → |